AGP
ABVX

Artia Global Partners’s Abivax ABVX Stock Holding History

Artia Global Partners’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.8M Sell
516,447
-84,300
-14% -$9.54M 12.7% 1
2026
Q1 		$66.9M Hold
600,747
– – 13.39% 2
2025
Q4 		$81M Buy
600,747
+375,294
+166% +$40.9M 11.48% 2
2025
Q3 		$19.1M Buy
+225,453
New +$13.8M 3.03% 11

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Artia Global Partners's ABVX Position: Q2 2026 in Review

Artia Global Partners reduced its Abivax (ABVX) stake by 14% in Q2 2026, selling an estimated $9.54M and leaving 516,447 shares worth $68.8M. The position accounts for 12.7% of the portfolio, ranked #1.

Artia Global Partners first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. The position peaked at $81M in Q4 2025. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Artia Global Partners held 516,447 shares of Abivax worth $68.8M as of Q2 2026.
  • Artia Global Partners sold 84,300 Abivax shares in Q2 2026, an estimated $9.54M.
  • Abivax made up 12.7% of Artia Global Partners's portfolio in Q2 2026, its #1 holding.
  • Artia Global Partners first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • Artia Global Partners's Abivax position peaked at $81M in Q4 2025.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Artia Global Partners's 13F filing for Q2 2026, filed 14 Aug 2026.